pharma news today obesity drugs glp-1 today drug supply Giants Bet on Next-Generation GLP-1 Treatments pharma news today glp-1 obesity
Description
Lixisenatide is cleared by glomerular filtration, followed by tubular reabsorption and subsequent metabolic degradation (126)
doi: 10.1111/dom.13494
This can be tough when youre on a GLP-1, so have regular check-ins with your doctor and make sure youre on the right dose
[DOI] [PubMed] [Google Scholar] 764.Tonneijck L., Smits M.M., Muskiet M.H.A., Hoekstra T., Kramer M.H.H., Danser A.H.J
Because peace of mind matters
In the 2022 SURMOUNT-1 study published in NEJM, three doses of tirzepatide were compared with placebo (1:1:1:1) to determine effects on percent weight change over the course of 72 weeks
